Tag Archives: Jim Greenwood

BIO2016 Keynote Videos: Jim Greenwood and Ron Cohen

BIO CONVENTION LOGO_VERTICAL_D_CMYK

In case you missed it, below are the keynote remarks from BIO President & CEO, Jim Greenwood and BIO Chair, Ron Cohen at the 2016 BIO International Convention in San Francisco. Jim Greenwood: Ron Cohen:

Corporate, Events  |  Leave a comment  |  Email This Post
Tags: , , , ,

My Keynote Address at the 2016 BIO International Convention

Greenwood_Jim_BTN

Yesterday, the voters of California had their say. The general election is upon us. It’s Clinton vs. Trump. Fasten your seat belts, folks. This election is going to be fascinating, but it’s not going to be pretty. Today, we turn to politics, and more specifically, the intersection between politics and policy. In a few minutes, we’ll hear from three Washington veterans. They’ll preview a race for the White House that figures to be unlike anything Read More >

Jim's Corner  |  Leave a comment  |  Email This Post
Tags: , , , , , ,

A Closer Look at AHIP’s Claims

new-bio-logo

This morning, in a letter to the editor of the New York Times, Marilyn Tavenner, President and CEO of America’s Health Insurance Plans (AHIP), attempted to lay the blame for higher healthcare costs and insurance premiums at the feet of America’s cutting-edge biopharma companies. AHIP has been peddling these falsehoods and misinformation for years.  Tavenner’s (and her organization’s) claims are—at best—uninformed. At worst, they are outright distortions deployed to hide the facts from patients who Read More >

Health  |  Leave a comment  |  Email This Post
Tags: , , , , , , ,

Jim Greenwood on “Time is Precious”

TimeIsPrecious_ScreenCap

Jim Greenwood, President & CEO, Biotechnology Innovation Organization discusses the organizations new campaign, Time is Precious. Greenwood says, “… if we are going to continue to create new treatments and cures we are going to have to continue to invest and attract investment capital.”  Watch the full interview below.

Events  |  Leave a comment  |  Email This Post
Tags: , , , ,

Jim Greenwood in New York Times: Specialty Tiers Limit Patient Access

Jim Greenwood

Today, the New York Times published a letter from Jim Greenwood, BIO’s President and CEO. Greenwood’s letter discusses the problems that expanded use of specialty tier cost-sharing by the insurance industry are posing for patients, limiting their access to lifesaving therapies and cures. Breakthrough treatments cost billions of dollars, and investors will only take on such risks if they can expect a reasonable return on their investment. The full text of the letter is below: To Read More >

Jim's Corner  |  Leave a comment  |  Email This Post
Tags: , , , , ,